RadNet, Inc. (RDNT): Cash & Equivalents
$767.22M
As of 2025-12-31
$726.27M
As of 2026-06-30
+81.7%
3-year compound annual growth
+49.7%
5-year compound annual growth
n/m
10-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $767.22M | +3.7% | 2026-03-02, Balance as of period end |
| 2024-12-31 | $740.02M | +116.0% | 2026-03-02, Balance as of period end |
| 2023-12-31 | $342.57M | +168.0% | 2025-03-03, Balance as of period end |
| 2022-12-31 | $127.83M | -5.0% | 2024-02-29, Balance as of period end |
| 2021-12-31 | $134.61M | +31.9% | 2023-03-01, Balance as of period end |
| 2020-12-31 | $102.02M | +154.0% | 2022-03-01, Balance as of period end |
| 2019-12-31 | $40.16M | +286.6% | 2021-03-16, Balance as of period end |
| 2018-12-31 | $10.39M | -79.8% | 2020-03-16, Balance as of period end |
| 2017-12-31 | $51.32M | +148.7% | 2020-03-16, Balance as of period end |
| 2016-12-31 | $20.64M | n/m | 2019-03-18, Balance as of period end |
| 2015-12-31 | $446.0K | n/m | 2018-03-19, Balance as of period end |
| 2014-12-31 | $3.0K | -99.0% | 2017-03-31, Balance as of period end |
| 2013-12-31 | $288.0K | -83.8% | 2016-03-30, Balance as of period end |
| 2012-12-31 | $1.78M | -14.9% | 2015-03-31, Balance as of period end |
| 2011-12-31 | $2.09M | +15.5% | 2014-03-31, Balance as of period end |
| 2010-12-31 | $1.81M | -82.1% | 2013-11-13, Balance as of period end |
| 2009-12-31 | $10.09M | n/a | 2012-03-13, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| RadNet, Inc. (RDNT) | 2025-12-31 | $767.22M | +3.7% |
| Fortrea Holdings Inc. (FTRE) | 2025-12-31 | $174.60M | +47.3% |
| Guardant Health, Inc. (GH) | 2025-12-31 | $378.20M | -28.0% |
| Caris Life Sciences, Inc. (CAI) | 2025-12-31 | $796.27M | n/m |
| Veracyte, Inc. (VCYT) | 2025-12-31 | $362.58M | +51.7% |
| CareDx, Inc. (CDNA) | 2025-12-31 | $65.43M | -43.0% |
| Quest Diagnostics Inc (DGX) | 2025-12-31 | $420.00M | -23.5% |
| Castle Biosciences Inc (CSTL) | 2025-12-31 | $116.73M | -2.5% |
| Fulgent Genetics, Inc. (FLGT) | 2025-12-31 | $50.19M | -9.0% |
Compare RDNT, FTRE, GH, CAI side by side · Screen every company in Services-Medical Laboratories ↗